Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis

RR Bannuru, CH Schmid, DM Kent… - Annals of internal …, 2015 - acpjournals.org
Background: The relative efficacy of available treatments of knee osteoarthritis (OA) must be
determined for rational treatment algorithms to be formulated. Purpose: To examine the …

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke

DM Kent, R Ruthazer, C Weimar, JL Mas, J Serena… - Neurology, 2013 - AAN Enterprises
Objective: We aimed to create an index to stratify cryptogenic stroke (CS) patients with patent
foramen ovale (PFO) by their likelihood that the stroke was related to their PFO. Methods: …

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification

DM Kent, RA Hayward - Jama, 2007 - jamanetwork.com
… For example, consider the benefits that 2 patients with type 2 diabetes mellitus and mild
hypertension (blood pressure of 140/90 mm Hg) might get from intensive blood pressure …

[HTML][HTML] Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

DM Kent, PM Rothwell, JPA Ioannidis, DG Altman… - Trials, 2010 - Springer
Mounting evidence suggests that there is frequently considerable variation in the risk of the
outcome of interest in clinical trial populations. These differences in risk will often cause …

Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced …

DG Kramer, TA Trikalinos, DM Kent… - Journal of the American …, 2010 - jacc.org
Objectives : The purpose of this study was to quantitatively assess the relationship between
therapy-induced changes in left ventricular (LV) remodeling and longer-term outcomes in …

Patent foramen ovale in cryptogenic stroke: incidental or pathogenic?

AA Alsheikh-Ali, DE Thaler, DM Kent - Stroke, 2009 - Am Heart Assoc
Background and Purpose— Patent foramen ovale (PFO) is significantly associated with
cryptogenic stroke (CS). However, even in patients with CS, a PFO can be an incidental finding. …

Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis

…, AA Alsheikh-Ali, A Tatsioni, BK Nallamothu, DM Kent - The Lancet, 2009 - thelancet.com
… We excluded trials that enrolled only patients with diabetes mellitus and those that enrolled
any patients with acute myocardial infarction within the previous 72 h. We also excluded …

Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects

DM Kent, E Steyerberg, D Van Klaveren - Bmj, 2018 - bmj.com
… 13 Dahabreh IJ, Hayward R, Kent DM. Using group data to treat individuals:
understanding heterogeneous treatment effects in the age of precision medicine and patient-centred …

Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke

DM Kent, JL Saver, SE Kasner, J Nelson, JD Carroll… - Jama, 2021 - jamanetwork.com
Importance Patent foramen ovale (PFO)–associated strokes comprise approximately 10% of
ischemic strokes in adults aged 18 to 60 years. While device closure decreases stroke …

Index event bias as an explanation for the paradoxes of recurrence risk research

IJ Dahabreh, DM Kent - Jama, 2011 - jamanetwork.com
… discrepancy can be reconciled by the following observation: among patients with a cryptogenic
stroke, those with a PFO tend to be younger, have much lower rates of diabetes mellitus